Recon: Amgen settles patent suit over Stelara biosimilar; FDA approves Opiant’s opioid overdose nasal spray
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy